Last updated on July 2018

Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza Complications


Brief description of study

The primary objective of this study is to evaluate the efficacy of a single, oral dose of Baloxavir Marboxil compared with placebo by measuring the time to improvement of influenza symptoms in patients with influenza presenting within 48 hours of symptom onset.

Clinical Study Identifier: NCT02949011

Contact Investigators or Research Sites near you

Start Over

Shionogi Clinical Trials Administrator Clinical ...

Shionogi Research Site
Gorna Oryahovica, Bulgaria
0.14miles

Shionogi Clinical Trials Administrator Clinical ...

Shionogi Research Site
Veliko Turnovo, Bulgaria
4.88miles

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.